Streetbeat News

Price Targets

BTCUSD

DOGEUSD

ETHUSD

Leading cryptocurrencies like Bitcoin and Ethereum traded flat ahead of Federal Reserve Chair Jerome Powell's speech, while Dogecoin saw a decline. Bitcoin's recent rally was driven by a central bank rate cut, and analysts predict a long-term bullish target for Bitcoin between $194K and $352K. The market sentiment remains one of 'Greed'.

Portfolio Pulse from Aniket Verma

September 30, 2024 | 1:58 am

BUYZ

IYT

UBER

Oppenheimer analyst raises Uber's price target to $95, citing increased food delivery penetration and potential for new user acquisition. Uber's partnership with Spirit Halloween and favorable delivery trends contribute to the positive outlook.

Portfolio Pulse from Lekha Gupta

September 27, 2024 | 8:11 pm

INTU

Piper Sandler analyst Arvind Ramnani has reiterated an Overweight rating on Intuit (NASDAQ:INTU) and maintained a price target of $768.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 7:57 pm

ACN

UBS analyst Kevin Mcveigh maintains a Buy rating on Accenture and raises the price target from $400 to $415.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 7:10 pm

ABBV

BMY

The FDA approved Bristol Myers Squibb's Cobenfy for schizophrenia without a black box warning, enhancing its potential for Alzheimer's psychosis treatment. Analysts project significant sales growth, with a raised price target for BMY. AbbVie is also developing a competing treatment.

Portfolio Pulse from Vandana Singh

September 27, 2024 | 7:06 pm

HOOD

Robinhood Markets (NASDAQ:HOOD) has received diverse analyst ratings over the past three months, with a mix of bullish, neutral, and bearish sentiments. Recent analyst actions include several raised price targets, reflecting a positive shift in sentiment. The average 12-month price target has increased by 6.72% to $22.22. Robinhood's financial performance shows strong revenue growth and net margin, but challenges in ROE and ROA.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 7:01 pm

BMEA

Scotiabank analyst George Farmer has maintained a Sector Outperform rating on Biomea Fusion (NASDAQ:BMEA) and raised the price target from $21 to $41.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 7:01 pm

TVTX

Citigroup analyst Carly Kenselaar maintains a Buy rating on Travere Therapeutics but lowers the price target from $23 to $19.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 6:57 pm

VIPS

Citigroup analyst Alicia Yap maintains a Buy rating on Vipshop Holdings and raises the price target from $15 to $18.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 6:54 pm

SCHW

Citigroup analyst Christopher Allen maintains a Neutral rating on Charles Schwab and lowers the price target from $75 to $72.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 6:50 pm